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DNA alkylation can cause mutations, epigenetic changes, and even cell death. All living organisms have evolved enzymatic and
non-enzymatic strategies for repairing such alkylation damage. AlkB, one of the Escherichia coli adaptive response proteins,
uses an α-ketoglutarate/Fe(II)-dependent mechanism that, by chemical oxidation, removes a variety of alkyl lesions from DNA,
thus aﬀording protection of the genome against alkylation. In an eﬀort to understand the range of acceptable substrates
for AlkB, the enzyme was incubated with chemically synthesized oligonucleotides containing alkyl lesions, and the reaction
products were analyzed by electrospray ionization time-of-ﬂight (ESI-TOF) mass spectrometry. Consistent with the literature,
but studied comparatively here for the ﬁrst time, it was found that 1-methyladenine, 1,N 6-ethenoadenine, 3-methylcytosine, and
3-ethylcytosine were completely transformed by AlkB, while 1-methylguanine and 3-methylthymine were partially repaired. The
repair intermediates (epoxide and possibly glycol) of 3,N 4-ethenocytosine are reported for the ﬁrst time. It is also demonstrated
thatO 6-methylguanineand5-methylcytosinearerefractorytoAlkB,lendingsupporttothehypothesisthatAlkBrepairsonlyalkyl
lesions attached to the nitrogen atoms of the nucleobase. ESI-TOF mass spectrometry is shown to be a sensitive and eﬃcient tool
for probing the comparative substrate speciﬁcities of DNA repair proteins in vitro.
1.Introduction
Nuclear and mitochondrial DNA is vulnerable to chemical
modiﬁcation from exogenous and endogenous sources.
Exogenous sources include radiation, oxidation and alkyla-
tion by organic and inorganic chemical agents; endogenous
cellular processes that contribute to the burden of genomic
damage include enzyme-promoted oxidation, alkylation,
and deamination of DNA [1, 2]. Because DNA has many
potential nucleophilic reaction sites, such as the nitrogen
and oxygen atoms on the bases and the oxygen atoms on
the sugar and phosphodiester backbone, small alkylating
agents from the environment or from internally generated
sources form a remarkably vast array of covalent alkyl-DNA
adducts [3]. These adducts challenge the cell in several ways.
They can cause mutations and hence irreversibly reprogram
the destiny of a somatic or germ cell. They jeopardize the
epigenetic pattern that imprints long term gene regulation.
Moreover, adducts can block DNA and RNA synthesis,
inhibit mRNA transcription and translation, and lead to
strand breaks. To avoid the undesired eﬀects of alkyl-DNA
lesions, living systems have developed a host of DNA repair2 Journal of Nucleic Acids
systems that act as front line defenses against the threats that
these adducts pose to cellular welfare [1, 2].
Thecellularresponse ofE.colitoalkylationisanintricate
and fascinating system that includes a speciﬁc sensor of DNA
alkylation burden (monitored as the alkyl phosphotriester
concentration) that, when triggered, results in the expression
of four proteins that aﬀord a robust global defense against
a broad array of alkyl DNA adducts [4–6]. When E. coli
experiences a low dose of a methylating agent, the alkylation
damagetoDNAcreatesasignalfortranscriptionalactivation
of the genes encoding the Ada, AlkA, AlkB, and AidB
proteins, each of which combats selective features of the
alkylation threat. The accumulation of those four proteins
aﬀords E. coli resistance to the mutagenicity and toxicity of
subsequent higher doses of the alkylating agent [7]. This
process in E. coli is called the adaptive response, which
is activated by the Ada protein following its alkylation by
the aforementioned DNA backbone alkyl phosphotriester
that serves as the cellular barometer for alkylation stress
[4, 5]. The AlkA enzyme is a DNA glycosylase and works
against selected alkylated bases, such as 3-methyladenine
and 7-methylguanine, among others [2]. The AidB protein
is proposed to be a defensive operative that sequesters or
chemically inactivates alkylating agents before they can react
with DNA; its exact enzymatic activity and mechanism,
however, are still unknown [8]. The AlkB protein was
discovered to be an α-ketoglutarate- and Fe(II)-dependent
oxidizing enzyme that can eﬃciently repair various DNA
and RNA alkyl lesions [9, 10]( Figure 1). The reported
substrate scope for the AlkB enzyme encompasses either
simple methylated or ethylated DNA lesions, such as 1MeA,
3MeC, 3EtC, 1MeG, and 3MeT, or even lesions with bridged
two-carbon units, such as eA, eC, and ethanoA [2, 4, 11, 12]
(Figure 2). AlkB has many mammalian homologs, including
ABH1 through ABH8 and FTO, some of which have also
been proposed or proved to act upon alkylated DNA and
RNA [2, 4, 11, 12]. Since the discovery of the enzymatic
properties of AlkB, research on this protein and its homologs
h a sb e c o m eaf e r t i l er e s e a r c ha r e a .
In this work we utilized chemical synthesis to prepare
structurally deﬁned lesions at speciﬁc sites within oligonu-
cleotides. The site-speciﬁcally modiﬁed oligonucleotides
were incubated with puriﬁed AlkB protein to allow a head-
to-head comparison of the substrate properties of various
alkyllesionsinthesameDNAsequencecontext.Thismethod
enabled us to monitor eﬃciently the ability of AlkB to repair
alkylation damage by a mass spectrometry tool employed
by us earlier in a limited manner with three DNA lesions
[13, 14]. This tool is demonstrated to have promise for
the high throughput comparative analysis of multiple and
diverse DNA repair substrates.
2.MaterialsandMethods
2.1. Oligonucleotide Synthesis. Oligonucleotides containing
the lesions in Figure 2 were made using solid-phase
phosphoramidite chemistry, and were deprotected, puri-
ﬁed and characterized as described previously [13, 15–
17]. For all nine lesions, the 16mer oligonucleotide
sequence was 5 -GAAGACCTXGGCGTCC-3 ,( X = lesion);
for O6MeG, an additional sequence was made (5 -
GAAGACCGXTGCGTCC-3 , X = O6MeG). The calculated
MWs of the oligonucleotides are shown in Table 1.D N A
concentration was determined by UV absorbance using the
extinction coeﬃcients (ε) at 260nm (For any alkylated base,
we substituted its extinction coeﬃcient with the extinction
coeﬃcient of its unmodiﬁed counterpart due to the small
diﬀerence between the values in the context of 16mer
DNA.).
2.2. In Vitro Reactions of Lesions with AlkB. All assays were
carried out with AlkBN11, a truncated form of AlkB in
which the ﬁrst eleven residues are deleted. AlkBΔN11 was
puriﬁed as described [14] and shown previously to have sim-
ilar activity to wild-type protein [14, 18]. All AlkB reactions
used similar conditions as previously described [13], the
major change being that all the reactions were performed in
HEPES buﬀer. Reactions were performed at 37◦Ci n4 5m M
HEPES (pH 8.0), 67μMF e ( N H 4)2(SO4)2·6H2O, 0.9 mM α-
ketoglutarate and 1.8mM ascorbate. DNA 16mer substrates
were as described in the previous section. Reactions were
conducted with 5μM DNA (see Figures 3-5 for detailed
information) and with or without 2.5μMA l k Bi na1 0 μL
volume. Reaction mixtures were kept on dry ice until ESI-
TOF MS analysis.
2.3. LC-ESI-TOF/MS Analysis. Oligonucleotide analyses
w e r ep e r f o r m e do na nA g i l e n tE S I - T O Fm a s ss p e c t r o m e t e r
(Palo Alto, CA). ESI was conducted using a needle voltage
of 3.5kV. Nitrogen gas was used with a setting of drying
10L/min and setting of nebulizer 15psig and a heated
capillary at 325◦C. Liquid chromatographic separations
were performed using a Zorbax SB-Aq column (2.1 ×
150mm; 3.5μm; Agilent Technologies, Palo Alto, CA)
with a ﬂow rate of 0.2mL/min. Solvent A was 10mM
ammonium acetate in water and solvent B was 100%
acetonitrile. A linear gradient was performed in the
following steps: 2% to 30% B over 30 minutes, 30% to
2 %Bo v e r5m i n u t e s ,a n d2 %t o2 %Bo v e r1 0m i n u t e s .
Data analyses were performed using Agilent MassHunter
Workstation software. For each individual lesion, we
assumed the 16mer DNA oligo with the lesion and the
oligo with the undamaged counterpart have identical
extinction coeﬃcients. In an eﬀort to achieve unbiased
quantiﬁcation of the repair reaction, we ﬁrst extracted
the UV chromatogram by using two m/z values that
bracket all expected oligonucleotide species. The time
interval encompassing all extracted UV peaks was used to
generate the ion chromatogram containing all expected
oligonucleotide species. We found the −4 charge envelope
of each target oligonucleotide. Then we chose the highest
peak in each envelope to generate oligonucleotide-speciﬁc
UV proﬁles, from which we selected the maximum UV
absorbance at 260nm to extract the ion abundance, whose
maximum peak in the envelope was used to calculate the
relative ratio between the oligonucleotides with the lesion or
the undamaged/transformed counterpart.Journal of Nucleic Acids 3
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Figure 1: Proposed mechanisms and examples (1MeA and eA) of AlkB-mediated enzymatic repair of alkyl DNA lesions.
N
N
N
N
N N
N
DNA DNA DNA
O
OO O
NH2
CH3 H3C
5MeC eC 3MeT
N
N N
N N
N N
N N
N N
N
DNA DNA DNA
O O
NH2 NH2
NH2
1MeG
CH3 CH3
O6MeG
H3C
1MeA
+
N
N N
N
N
N
N N
N
DNA DNA DNA
O O
NH2 NH2
H3C
H3C
eA 3MeC 3EtC
+ +
Figure 2: Chemical structures and abbreviations of DNA lesions
screened as possible repair substrates for the AlkB protein using
ESI-TOF mass spectrometry. The repair target within each base is
highlighted in red.
3. Results
Nine 16mer oligonucleotides were chemically synthesized
containing the alkyl-DNA adducts shown in Figure 2.
The sequence used was 5 -GAAGACCTXGGCGTCC-3 ; the
ﬂanking sequence of each lesion (X) was identical, ﬁxing the
sequence context for the repair reaction. The 16mers with
each lesion were incubated in HEPES buﬀer with the known
cofactors for the AlkB reaction: α-ketoglutarate, iron in the
+2 oxidation state, and ascorbate (see Section 2 for details).
For each lesion, two sets of experiments were conducted, one
with the AlkB protein and one in the reaction buﬀer without
the AlkB protein. Following the repair reaction, ESI-TOF
mass spectrometry was used to detect the reaction products.
The 16mer oligonucleotides demonstrated a good signal in
the −4 charge envelope of the ESI-TOF spectra. To give one
example to illustrate the method of analysis, the molecular
weight (MW) of the 1MeG lesion in the 16mer is calculated
as 4918.87Daltons for the neutral species, and the MW of its
monoisotopic peak (all 12C, 14N, etc) when migrating with 4
negativecharges(the −4chargeenvelope)intheelectricﬁeld
of the spectrometer is calculated as having an m/z of 1228.71
(all MW information is shown in Table 1). The multiple
peaks in each −4 charge envelope reﬂect the number of 13C
or other heavier isotopes (Figure 3). Again using 1MeG as
the example, its monoisotopic peak is observed as 1228.62.
This experimental result is considered consistent with the
theoretical calculation. The next peak in that envelope has
an m/z of 1228.87, 0.25amu larger than the 1228.62peak,
which indicates a species containing 13C, 15N or another
isotope that adds a nominal mass of 1.0 to the total weight
of the 16mer (e.g., 0.25 = m/z = one 13C/a charge state of 4).
Additional peaks in the spectrum represent additional heavy
isotopes within the parental 16mer.
3.1. N1-Methylguanine. N1-Methylguanine (1MeG) (Fig-
ure 2)h a sb e e nf o u n db o t hin vitro [19]a n din vivo [20].
The glycosylase AAG can repair the 1MeG lesion in vitro
[21]. Our group and others have observed that the AlkB
protein can repair 1MeG both in vivo and in vitro [15, 22].
In the in vivo assay, AlkB can partially overcome the strong
block of 1MeG to replication (lesion bypass increases from
2% in AlkB− cells to 16% in AlkB+ cells). Similarly, AlkB
causes a reduction in the mutagenicity of 1MeG from a high
frequency of 80% in AlkB− c e l l st o4 %i nA l k B +c e l l s[ 15].
In the in vitro incubation reaction without AlkB protein,
we observed the monoisotopic peak of the 1MeG 16mer4 Journal of Nucleic Acids
Table 1:CalculatedandobservedmonoisotopicmolecularweightofoligonucleotidesandintermediatespresentintheAlkBrepairreactions.
Lesion or base MW (calculated) m/z (calculated) m/z (observed)
of neutral species −4 charge monoisotopic peak −4 charge monoisotopic peak
G 4904.86 1225.21 1225.11
1MeG 4918.87 1228.71 1228.61/2
O6MeG 4918.87 1228.71 1228.62/3
A 4888.86 1221.21 1221.12/23
1MeA 4902.88 1224.71 1224.67
eA 4912.86 1227.21 1227.22/4
eA epoxide 4928.86 1231.21 1231.23
eA glycol 4946.87 1235.71 1235.72
C 4864.85 1215.20 1215.20/1
3MeC 4878.87 1218.71 1218.72
3EtC 4892.88 1222.21 1222.23
5MeC 4878.87 1218.71 1218.73
eC 4888.85 1221.20 1221.21/2
eC epoxide 4904.84 1225.20 1225.19
eC glycol 4922.86 1229.71 1229.69
T 4879.85 1218.95 1218.97
3MeT 4893.87 1222.46 1222.49
oligonucleotide for the −4 charge state at m/z of 1228.62
(Figure 3(a)), which correlates well with the calculated value
for the −4 charge monoisotopic peak (m/z = 1228.71). In
the presence of the AlkB protein (Figure 3(b)), we found
47% of the 1MeG was repaired to the undamaged guanine
base (−4 charge m/z = 1225.11) and 53% of the 1MeG
(−4 charge m/z = 1228.61) was unchanged. Whereas many
other lesions, such as 1MeA, 3MeC, 3EtC, or eA [13, 15],
are fully transformed, 1MeG is not. It is noteworthy that its
incomplete repair observed here is also in line with studies
done on the same lesion in vivo, which showed that 1MeG
hasarelativelyloweﬃciencyoflesionbypass(16%forAlkB+
E. coli)[ 15].
3.2. O6-Methylguanine. O6-Methylguanine (O6MeG) (Fig-
ure 2) is formed when the genome is under alkylation attack
[23] and is an especially potent driver of G → A transition
mutations [24]. O6MeG is formed both endogenously [25,
26]a n de x o g e n o u s l y[ 27]. E. coli has two repair proteins
for such damage. The constitutive Ogt and the inducible
Ada proteins reverse methylation damage by transferring the
methyl group to one of the internal cysteine residues on each
protein.Thistransferisastoichiometric(“suicidal”)reaction
that irreversibly inactivates the repair proteins [5]; thus, Ogt
and Ada are not true enzymes since their active sites cannot
be regenerated. The mismatch repair (MMR) pathway has
also been reported to play an important role in the response
to O6MeG [28]. In the present work, it was our goal to test
whether AlkB can also act upon and possibly repair O6MeG.
For the O6MeG lesion, we synthesized two sets of
16mers and named them as TXGa n dG XT according to
the neighboring nucleosides (see Section 2). In the mass
spectra of both TXG (Figure 3(c)) and GXT( Figure 3(e))
in the absence of the AlkB enzyme, we observed m/z values
of 1228.62 (TXG) and 1228.63 (GXT) for the −4 charge
monoisotopic peak, which are in good agreement with the
calculated m/z of 1228.71. For the reactions with AlkB
protein, we did not observe any repaired product nor any
structural modiﬁcations (as shown below, AlkB sometimes
f u l l yr e m o v e st h ea l k y lg r o u pb u ti ts o m e t i m e sc a nc r e a t e
stable oxidized products that are distinct from both the
starting material and an unmodiﬁed base product). The
observed products of the reaction were identical to the
starting material: m/z of 1228.62 for TXG( Figure 3(d)) and
of 1228.62 for GXT( Figure 3(f)). These results indicate
O6MeG is not a substrate forAlkB in the invitro experiments
under the reaction conditions tested, which provide for full
transformation of other lesions, such as 1MeA and eA.
3.3. N1-Methyladenine. N1-Methyladenine (1MeA) (Fig-
ure 2)isformedmainlyinsingle-strandedDNAbyalkylating
agents and has been detected in vitro [3, 9, 10, 19, 29–
31]a n din vivo [3, 32–35]. These alkylating agents include
SN2 agents, such as methylmethanesulfonate (MMS) and the
naturally occurring methyl halides [5]. The AlkB enzyme
repairs 1MeA both in vitro and in vivo [15]. Studies of 1MeA
in vivo reveal that the lesion imposes a severe block to DNA
replication in AlkB− cells, which is completely removed
in AlkB+ cells. These results underscore the physiological
relevance of the AlkB system for countering the toxicity of
this base. While very toxic, 1MeA is only weakly mutagenic
in both AlkB− and AlkB+ cells [15].
In our in vitro study of 1MeA repair, the lesion was com-
pletelyrepairedtotheundamagedbaseadenine(Figure 3(h),
m/z = 1221.12), while no change occurred in the absence
of the AlkB protein (Figure 3(g), m/z 1224.67). The in vitro
results conﬁrm that 1MeA is a good substrate for AlkB.
Moreover, the current observations correlate very well with
the strong reparability of 1MeA suggested by earlier in vivo
lesion bypass studies [15].Journal of Nucleic Acids 5
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Figure 3: ESI-TOF analysis of 16mer reactants and products from
the in vitro incubation reactions of alkylated lesions and AlkB
protein. Data represent the −4 charge envelopes; multiple ion mass
peaks associated with each envelope reﬂect mostly the number of
13Ca t o m si ne a c h−4 charged packet. The monoisotopic peak (all
12C, 14N, etc.) value is labeled above each peak envelope. (a) 1MeG;
(b) 1MeG + AlkB; (c) O6MeG (TXG); (d) O6MeG (TXG) + AlkB;
(e) O6MeG (GXT); (f) O6MeG (GXT) + AlkB; (g) 1MeA; (h) 1MeA
+ AlkB; (i) eA; (j) eA + AlkB.
3.4.1,N6-Ethenoadenine. Theformationof1,N6-ethenoade-
nine (eA) (Figure 2) may result from the reaction of adenine
with products of unsaturated lipid peroxidation [36–39]o r
arise from normal physiological conditions in both rodents
and humans [40, 41]. The eA lesion is believed to be a
good biomarker of inﬂammation and oxidative stress. This
lesion may also be formed by exposure to the common
industrial agent vinyl chloride and its metabolites, such as
chloroacetaldehyde [42]. In duplex DNA, eA can be repaired
by the base excision repair (BER) pathway in vitro [21, 43]
and in vivo [44, 45]. Recently, it was shown that AlkB and
its human homolog ABH2 and ABH3 can repair eA in vitro
[13, 46, 47]. The direct reversal mechanism is also likely to
be operative in vivo. In AlkB- cells, eA is 35% mutagenic, but
less than 0.3% mutagenic in AlkB+ cells [13].
In our present in vitro study using mass spectrometry
to monitor the repair reaction, the oligonucleotide with
eA was observed at m/z of 1227.22 for its −4 charge
monoisotopic peak in the absence of AlkB (Figure 3(i)).
In the presence of AlkB, the eA lesion was mostly con-
verted to the undamaged product, adenine (m/z = 1221.23,
Figure 3(j)). The m/z diﬀerence at the −4 charge state
between the eA and A is 5.99Daltons, which corresponds
to the ∼24Dalton MW diﬀerence (two carbon atoms) of
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Figure 4: ESI-TOF analysis of 16mer reactants and products from
the in vitro incubation reactions of eA and eC lesions with the AlkB
protein. Data represent the −4 charge envelopes; multiple ion mass
peaks associated with each envelope reﬂect mostly the number of
13Ca t o m si ne a c h−4 charged packet. The monoisotopic peak (all
12C, 14N, etc.) value is labeled above each peak envelope. (a) eA +
AlkB; (b) eC + AlkB.
the two products. We also observed peak clusters consistent
in MW with epoxide and glycol intermediates (Figures 1
and 4(a)), which are consistent with previous observations
[13].
3.5. N3-Methylcytosine and N3-Ethylcytosine. N3-Methylcy-
tosine (3MeC) (Figure 2) has been detected both in vitro
[3, 9, 19, 29–31, 48, 49]a n din vivo [3, 20, 34, 49].
The corresponding ethyl homolog, N3-ethylcytosine (3EtC)
(Figure 2), also has been detected in vitro [3, 29]a n din
vivo [3, 50]. In E. coli, the AlkB protein has good activity
against 3MeC and 3EtC both in vitro and in vivo [9, 10, 15].
The mutation frequency of 30% for both 3MeC and 3EtC in
AlkB- cells dropped to <2% in AlkB+ cells [15].
The m/z values of the starting material for 3MeC and
3EtCintheESI-TOFmassspectrawere1218.72(Figure 5(a))
and1222.23(Figure 5(c)),respectively.Afterincubationwith
AlkB protein, the 3MeC and 3EtC residues were completely
repaired to the undamaged cytosine (m/z of 1215.21 for
3MeC, Figure 5(b); and of 1215.20 for 3EtC, Figure 5(d)).
The complete in vitro repair of these lesions establishes both
as good substrates for AlkB, consistent with ﬁndings from
previous in vivo bypass and mutagenesis assays [15].6 Journal of Nucleic Acids
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Figure 5: ESI-TOF analysis of 16mer reactants and products from
the in vitro incubation reactions of alkylated lesions and AlkB
protein. Data represent the −4 charge envelopes; multiple ion mass
peaks associated with each envelope reﬂect mostly the number of
13Ca t o m si ne a c h−4 charged packet. The monoisotopic peak (all
12C, 14N, etc.) value is labeled above each peak envelope. (a) 3MeC;
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3.6. 5-Methylcytosine. 5-Methylcytosine (5MeC) (Figure 2)
is the naturally methylated form of cytosine seen in prokary-
otes and eukaryotes. This methylation does not disturb
the Watson-Crick base pairing ability of cytosine, and it
is not recognized as DNA damage. 5MeC is an important
epigenetic biomarker for mammalian development. It also
occurs in bacterial systems as a marker for restriction
endonucleases and as a marker used in a specialized type
of mismatch repair [51]. Recently, researchers found TET1,
an α-ketoglutarate- and Fe(II)-dependent enzyme, that can
oxidize 5MeC to 5-hydroxymethylcytosine [52]. We assessed
the ability of AlkB to act similarly on 5MeC.
In the reaction without the AlkB protein, the monoiso-
topic −4c h a r g ep e a ko f5 M e Ca p p e a r e da tm / z= 1218.73
(Figure 5(e)). In the incubation reaction with 5MeC plus
AlkB, the only peak in the spectrum corresponded to 5MeC
(m/z = 1218.73, Figure 5(f)). No peak corresponding to
5-hydroxymethylcytosine or the fully demethylated product,
cytosine, was observed, indicating that 5MeC is not an AlkB
substrate under the conditions of analysis.
3.7. 3,N4-Ethenocytosine. 3,N4-Ethenocytosine (eC)
(Figure 2) is produced from the same precursors and
by the same pathways that generate eA in DNA [36–38, 53].
The BER pathway (human thymine-DNA-glycosylase
(hTDG) in human and double-stranded uracil-DNA-
glycosylase (dsUDG) in E. coli) has been shown to suppress
the occurrence of this adduct [44, 53]. In E. coli,A l k Bh a sa
modest eﬀect on eC toxicity, but reduces the mutation of eC
from 82% in AlkB− cells to 37% in AlkB+ cells [13].
In our in vitro studies, the reaction of eC oligonucleotide
without the AlkB protein gave a −4 envelope signal at m/z
= 1221.22 (Figure 5(g)). The reaction with AlkB showed eC
to be a signiﬁcant substrate for AlkB protein, although the
lesion was not fully repaired under conditions that fully
repaired other adducts, such as 1MeA and 3MeC. Only 67%
of the eC lesion was consumed (to cytosine, epoxide, and
glycol) and 33% of the eC remained intact (signal at m/z
= 1221.21, Figure 5(h)). We also observed a small amount
of the epoxide and possibly glycol products (Figure 4(b)),
comparable to the products found in the eA repair reaction
by AlkB [13]. These results strongly support the conclusions
from earlier in vivo experiments, and further show that eC
may be repaired by AlkB via an epoxide intermediate, which
is hydrolyzed to a glycol and then may be released as glyoxal
(Figure 1). This ESI-TOF analysis of eC with AlkB is the ﬁrst
demonstration of the detailed mechanism and intermediates
of this lesion repaired by the AlkB protein in vitro.
3.8. N3-Methylthymine. N3-Methylthymine (3MeT) (Fig-
ure 2)h a sb e e nf o u n db o t hin vitro [3, 19, 29, 31, 54]
and in vivo [54, 55] and is formed through the reaction
of thymine with SN2 alkylating agents such as MMS. This
a d d u c th a sb e e nr e p o r t e da sav e r yw e a ks u b s t r a t ef o r
AlkB in vivo [15]. Recently, another α-ketoglutarate- and
Fe(II)-dependent demethylase, FTO (fat mass and obesity
associated) protein has been reported as an enzyme that can
eﬃciently repair 3MeT in ssDNA [12, 56, 57].
Our in vitro experiments conﬁrm the ability of AlkB to
eﬀectuate the partial repair of 3MeT as shown in the in vivo
assays. In the absence of the AlkB protein, the −4e n v e l o p e
monoisotopic peak of 3MeT appeared at m/z of 1222.49
(Figure 5(i)). In the reaction with AlkB protein, 47% of
3MeTwasconvertedtothymine(m/z=1218.97,Figure 5(j)),
leaving 53% unrepaired (m/z = 1222.49, Figure 5(j)).
4. Discussion
4.1. Advantages of Chemical Synthesis and ESI-TOF Mass
Spectrometry. In the in vitro experiments described above,
puriﬁed AlkB protein was incubated with oligonucleotides
containing individual DNA lesions within the same sequence
context.Therearetwowayscommonlyusedtogeneratealkyl
lesions in DNA. The ﬁrst is by treatment of an unmodiﬁed
oligonucleotide of known sequence with alkylating agents,Journal of Nucleic Acids 7
such as MMS and N-methyl-N
 -nitro-N-nitrosoguanidine
(MNNG), to generate a spectrum of alkyl lesions within
the oligomer. The second approach, which was used in
this work, utilizes chemical synthesis to incorporate a
modiﬁed DNA base into a deﬁned sequence, thus providing
homogeneous targeted damage to be used as a substrate
for repair, replication, or other biochemical assays. All
nine lesions investigated in this paper were synthesized in
the same 16mer background, thus eliminating sequence
context as a variable for rank-ordering the extent to which
each lesion may be repaired by the AlkB protein. We
then utilized high-resolution liquid chromatography-mass
spectrometry (LC-MS) to detect the reaction products. The
ESI-TOF mass spectrometry method utilized here allowed
us to achieve good signal with only 20pmol of oligonu-
cleotide, establishing it as a viable tool for DNA repair
studies.
4.2. Substrate Scope for AlkB and Correlation of In Vitro Data
with In Vivo Results. As reported in the above sections, we
observed that the AlkB protein can repair diﬀerent alkyl
lesions to varying extents. Under the current experimental
condition, good substrates for AlkB were 1MeA, eA, 3MeC,
and 3EtC, which were completely repaired or transformed
after a one-hour incubation at 37◦C, which mimics human
physiological temperature. The 1MeG, eC, and 3MeT lesions
a r el e s se ﬃcient substrates for AlkB under the conditions
tested, and the extent of their transformation varied from
47% to 67%. The repair eﬃciency trends from the in vitro
experiments performed here are in line with previously
published in vivo results from lesion bypass and mutagenesis
assays performed in our laboratory using single-stranded
viral genomes site-speciﬁcally modiﬁed with each lesion,
which were passaged through AlkB− and AlkB+ E. coli
[13,15].Theoxygen-attachedlesionO6MeG in two sequence
contexts and the carbon-attached lesion 5MeC were not
repaired or transformed at all in the AlkB reactions under
the conditions tested. These results, combined with others
in the literature, suggest that AlkB repairs only those alkyl-
DNA lesions that are attached via the nitrogen atoms of
the bases and not lesions bound to carbon or oxygen
atoms.
5. Conclusions
There were two goals to the present study. The ﬁrst was
to expand our earlier study of DNA repair in which we
used ESI-TOF to study repair of eA [13]. That work was
a systematic enzymatic analysis including demonstration
that this tool can capture real-time snapshots of the repair
reaction as it progresses from starting material, through
intermediates, and to products. In the present work, for the
sake of simplicity, one time point was chosen (that at which
eA repair was complete in the previous kinetic analysis).
At that time point (one hour), the ESI-TOF method is
shown to be of great value as a tool for rapid comparison
of many structurally diﬀerent substrates. Having shown the
potentialofthistechnologyforreal-timemonitoringofDNA
repairreactions,futurestudiescanuseESI-TOFandisotope-
labeling with multiple time points for each lesion to deﬁne
more accurately the kinetic parameters of their individual
repair reactions.
The second goal of this work was to probe, more
completely and systematically than in the past, the structural
requirements of the AlkB enzyme. Among the nine lesions
studied, we present direct new evidence for AlkB repair
of eC by a direct reversal mechanism, and buttress the
growing body of evidence that lesions connected to bases
at nitrogens are the major targets of this enzyme. Similar
analyses using the same substrate library as in the present
study could be performed using the eight known human
AlkB homologs as well as the FTO protein, TET1, and
other α-ketoglutarate- and Fe(II)-dependent enzymes. Such
studies will help further to deﬁne how this class of proteins
helps to protect the genome from DNA damage or helps to
modify gene expression programs.
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